EBI3, 20µl

EBI3, 20µl 

To Order Contact us: caitlyn@ucb-bioproducts.com

Mouse Epstein Barr Virus Induced Protein 3 (EBI3) ELISA Kit

RD-EBI3-Mu-48Tests 48 Tests
EUR 533

Mouse Epstein Barr Virus Induced Protein 3 (EBI3) ELISA Kit

RD-EBI3-Mu-96Tests 96 Tests
EUR 740

Human Epstein Barr Virus Induced Protein 3 (EBI3) ELISA Kit

RDR-EBI3-Hu-48Tests 48 Tests
EUR 522

Human Epstein Barr Virus Induced Protein 3 (EBI3) ELISA Kit

RDR-EBI3-Hu-96Tests 96 Tests
EUR 724

Mouse Epstein Barr Virus Induced Protein 3 (EBI3) ELISA Kit

RDR-EBI3-Mu-48Tests 48 Tests
EUR 557

Mouse Epstein Barr Virus Induced Protein 3 (EBI3) ELISA Kit

RDR-EBI3-Mu-96Tests 96 Tests
EUR 774

EBI3 siRNA

20-abx914889
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

EBI3 siRNA

20-abx914890
  • EUR 551.00
  • EUR 732.00
  • 15 nmol
  • 30 nmol

EBI3 Antibody

24814-100ul 100ul
EUR 390

EBI3 Antibody

24818-100ul 100ul
EUR 390

EBI3 Antibody

42991-100ul 100ul
EUR 252

EBI3 Antibody

1-CSB-PA007360GA01HU
  • EUR 597.00
  • EUR 333.00
  • 150ul
  • 50ul
Description: A polyclonal antibody against EBI3. Recognizes EBI3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB

EBI3 Antibody

1-CSB-PA007360LA01HU
  • EUR 317.00
  • EUR 335.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EBI3. Recognizes EBI3 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200

EBI3 Antibody

1-CSB-PA006315
  • EUR 222.00
  • EUR 195.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against EBI3. Recognizes EBI3 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000

EBI3 Antibody

DF8363 200ul
EUR 304
Description: EBI3 Antibody detects endogenous levels of total EBI3.

EBI3 Antibody

ABD8363 100 ug
EUR 438

anti-EBI3

YF-PA25494 50 ul
EUR 334
Description: Mouse polyclonal to EBI3

anti-EBI3

YF-PA25495 50 ul
EUR 334
Description: Mouse polyclonal to EBI3

EBI3 antibody

70R-16983 50 ul
EUR 435
Description: Rabbit polyclonal EBI3 antibody

EBI3 antibody

10R-6641 100 ug
EUR 403
Description: Rat monoclonal EBI3 antibody

EBI3 protein

30R-2593 20 ug
EUR 336
Description: Purified recombinant Human EBI3 protein

EBI3 protein

30R-2594 20 ug
EUR 383
Description: Purified recombinant Mouse EBI3 protein

EBI3 antibody

70R-3648 50 ug
EUR 467
Description: Rabbit polyclonal EBI3 antibody raised against the middle region of EBI3

EBI3 Antibody

4967-002mg 0.02 mg
EUR 171.82
Description: EBI3 Antibody: EBI3 is a subunit in two distinct heterodimeric cytokines: interleukin-27 (IL-27) and IL-35. Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naïve but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 (also known as TCCR) and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet. IL-35 is composed of EBI3 and the p35 subunit of IL-12 and has been reported to have therapeutic effects against collagen-induced arthritis by expanding the population of regulatory T cells and suppressing Th17 cells. At least two isoform of EBI3 are known to exist.

EBI3 Antibody

4967-01mg 0.1 mg
EUR 436.42
Description: EBI3 Antibody: EBI3 is a subunit in two distinct heterodimeric cytokines: interleukin-27 (IL-27) and IL-35. Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naïve but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 (also known as TCCR) and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet. IL-35 is composed of EBI3 and the p35 subunit of IL-12 and has been reported to have therapeutic effects against collagen-induced arthritis by expanding the population of regulatory T cells and suppressing Th17 cells. At least two isoform of EBI3 are known to exist.

EBI3 Antibody

4977-002mg 0.02 mg
EUR 171.82
Description: EBI3 Antibody: EBI3 is a subunit in two distinct heterodimeric cytokines: interleukin-27 (IL-27) and IL-35. Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naïve but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 (also known as TCCR) and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet. IL-35 is composed of EBI3 and the p35 subunit of IL-12 and has been reported to have therapeutic effects against collagen-induced arthritis by expanding the population of regulatory T cells and suppressing Th17 cells. At least two isoform of EBI3 are known to exist.

EBI3 Antibody

4977-01mg 0.1 mg
EUR 436.42
Description: EBI3 Antibody: EBI3 is a subunit in two distinct heterodimeric cytokines: interleukin-27 (IL-27) and IL-35. Like interleukin-23 (IL-23), IL-27 is a recently discovered member of the IL-6/IL-12 family of proinflammatory and immunoregulatory cytokines. It exists as a heterodimer composed of the p40-related protein EBI3 and an IL-12 p35-related protein termed p28. IL-27 is produced after activation by antigen-presenting cells and induces proliferation of naïve but not memory CD4+ T-cells. It acts by binding to its receptor WSX-1 (also known as TCCR) and gp130 which results in the activation of a Jak/STAT signaling cascade, suggesting the IL-27 is involved in the regulation of immune processes. It has been suggested that IL-27 can also be used as a therapeutic agent against cancer as it can also induce tumor-specific anti-tumor activity mediated through CD8+ T-cells, IFN-gamma, and T-bet. IL-35 is composed of EBI3 and the p35 subunit of IL-12 and has been reported to have therapeutic effects against collagen-induced arthritis by expanding the population of regulatory T cells and suppressing Th17 cells. At least two isoform of EBI3 are known to exist.

EBI3 Peptide

46-971P 0.1 mg
EUR 338
Description: (IN) EBI3 Peptide

EBI3 Peptide

4967P 0.05 mg
EUR 164.75
Description: (CT) EBI3 peptide

EBI3 Peptide

4977P 0.05 mg
EUR 164.75
Description: (IN) EBI3 peptide

Ebi3 Polyclonal Antibody

ES4372-100ul 100ul
EUR 279
Description: A Rabbit Polyclonal antibody against Ebi3 from Human/Mouse. This antibody is tested and validated for WB, ELISA, WB, ELISA

EBI3, 20µl